Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Fluxion Biosciences and Swift Biosciences announced a jointly developed workflow for oncology clinical research designed to detect somatic mutations from a routine blood draw. The workflow uses Fluxion’s IsoFlux System for circulating tumor cell enrichment and Swift’s Accel-Amplicon technology for high-sensitivity variant detection using low starting inputs.
Magellan Diagnostics received FDA 510(k) clearance to market its LeadCare Plus Blood Lead Testing System in the U.S. for the quantification of lead levels in blood.
BioTek released the Synergy Neo2 Multi-Mode Reader, which is designed for speed and ultra-high performance and incorporates BioTek’s patented Hybrid Technology with independent optical paths. Continuously variable bandwidth quadruple monochromators, sensitive high transmission filter-based optics, and up to four photomultiplier tubes provide fast measurements with excellent results, according to a company statement.
New England Biolabs released the NEBNext Library Quant Kit for Illumina, a qPCR-based solution for accurate next-generation sequencing library quantitation.
Total Lab Care’s Laboratory Essentials course has been approvedT for 3.5 hours of P.A.C.E. continuing education credits. This Web-based interactive training program comprises 10 individual lessons and reviews CLIA rules and regulations and laboratory operations from preanalytical to postanalytical processes, including laboratory testing requirements (pipetting, safety, equipment operation, etc.).
CLSI’s Excellence Awards are bestowed on volunteers who are dedicated and committed to the organization’s mission and who significantly contribute their services to the development, implementation, and promotion of consensus standards. The winners were nominated by their peers and then selected by the CLSI Awards Committee and announced in July.
Ariosa Diagnostics’ proprietary Forte software received the CE mark—a significant achievement toward the continued expansion of the Harmony Prenatal Test in Europe and worldwide, according to a company statement.
Biocept launched its c-MET amplification detection test. This diagnostic assay, which uses a blood-based liquid biopsy, has the potential to help physicians identify patients who may be receptive to certain gastric and non-small cell lung cancer treatments.
Biomedical Polymers has received ISO 13485:2003 certification for its Quality Management System for the manufacture of Medical Devices. In order to meet these requirements for certification, BMP upgraded its quality management system to assist in achieving increased efficiencies, higher performance, and reduced operational costs.
SeraCare Life Sciences’ new precision medicine business unit has launched its first product, the Seraseq Solid Tumor Mutation Mix—I (AF20), a biosynthetic reference material designed to evaluate the performance of next-generation-sequencing–based tumor profiling assays.
